Professional study of Alpha Emitters by Growth, Trends, Forecast (2019-2024)
Axiom MRC added a report on, “Alpha
Emitters Market, By Radionuclide Type, Medical
Application, End User and Geography - Global Market Share, Trend Analysis &
Forecast Up To 2024” The
global alpha emitters market has gained sustainable growth owing rising
incidences of cardiac & cancer ailments and high availability of
radiopharmaceuticals.
Alpha
Emitters Market Introduction:
In therapeutic
radiopharmaceuticals, radionuclides with alpha emitters plays a significant
role in treating cancers. Some properties such as short range and deposited
energy in unit length of pathway augment the effect of alpha particle in
destroying the DNA of cancer cells. Therefore, recognizing this capacity involves
more investigations over the biological effect of these particles on human
body. Properties of alpha emitters has led to exert profound differences
between this field and other fields of nuclear medicine.
The market is
further boosted by technological advancements in alpha emitters by various
vendors across the globe coupled with increased awareness about the potential
benefits of targeted alpha therapy (TAT). Alpha emitters are presently used in
the process of targeted alpha therapy (TAT), in which an alpha emitter
radionuclide exposes a certain amount of radiation dosage to tumour cells, and
thus destroy the respective cancer cells.
Alpha
Emitters Market Segmentation Overview:
Alpha
Emitters Market by Radionuclide Type:
Based on
radionuclide type, the global alpha emitters market is segmented into Actinium
(Ac-225), Astatine (At-211), Bismuth (Bi -213), Bismuth (Bi-212), Lead
(Pb-212), Radium (Ra-223) and Terbium (Tb-149). Increasing use of alpha emitter
radionuclides for therapeutic purposes are a new approach to tackle cancer and
related issues.
Alpha
Emitters Market Medical Application:
The medical
application segment is categorized into bone metastasis, endocrine tumors,
glioma, lymphoma, melanoma, ovarian cancer, pancreatic cancer and thyroid.
Alpha
Emitters Market End User:
The major end
users considered in the study are hospitals, imaging centres and research
laboratories.
Alpha
Emitters Market Geography:
By geography, the
global alpha emitters market is studied across the countries of key regions
such as, North America, Europe, Asia Pacific and rest of the world. North
America accounted for the largest share in 2017, followed by Europe and
Asia-Pacific.
Alpha
Emitters Market Leading Partners:
Key market
players in the alpha emitters market include Actinium Pharmaceuticals, Alpha
Tau Medical, Bayer AG, Cardinal Health, Inc., GE Healthcare, IBA RadioPharma
Solutions, Nordion, Inc., NTP Radioisotopes, Plexus NSD, Siemens Healthcare and
Triad Isotopes.
About
Axiom MRC:
Axiom Market Research & Consulting™ (also known as
Axiom MRC), is a full-service market research and data analytics firm, driven
by a simple aim of providing key market intelligence to companies to assist
them in taking informed business decisions pertaining to their marketing
strategy, investments, new product launches, market competition, consumer or
end users, social media trends etc.
Media
Contact:
Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: sales@axiommrc.com
Tel: +1(845)875-9786, +44(0) 20 238697007
Comments
Post a Comment